Rare diseases
Investigational molecules
Locations
Back to Germany89 clinical trials in Schwerin, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Phase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients
GermanyStudy of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
GermanyEfficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1
GermanyPhase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
GermanyPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
GermanyPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
GermanyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GermanyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
GermanyStudy on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1
GermanyStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
GermanyEfficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years
GermanyA Phase 3 Study of Once‑Monthly PF‑08653944 vs Placebo for Weight Loss in Adults with Overweight or Obesity
GermanyThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on respiratory infections including trials evaluating vaccines against RSV and human metapneumovirus. Additional research examines improved influenza protection in adults over 50 years with stable comorbidities.
Multiple investigations into treatments for plaque psoriasis, with emphasis on evaluating new therapeutic options for moderate to severe cases. Research includes long-term safety assessments and comparative efficacy studies.
Comprehensive cancer studies including breast cancer, colon cancer, and lymphoma treatments. Trials evaluate pre-operative therapies, immunotherapy combinations, and specialized protocols for pediatric patients.
Research focusing on Alzheimer's Disease, migraine prevention, and neurological conditions. Studies evaluate new therapeutic approaches and compare treatment efficacy with existing medications.
Extensive research into Major Depressive Disorder and ADHD, investigating new therapeutic approaches and long-term treatment outcomes. Studies include both adult and adolescent populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
